| Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs | Sarah de Crescenzo | 06/05/20 | Boston |
| IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout | Ben Fidler | 08/03/17 | Boston |
| Eli Lilly Pays Nektar $150M Up Front For Autoimmune Drug Rights | Frank Vinluan | 07/24/17 | Indiana |
| Bio Roundup: Trump News, Anthem’s Stand, Diversity by 2056 & More | Ben Fidler | 01/27/17 | National |
| Just Four Months After Series A, Delinia Sells to Celgene For $300M | Ben Fidler | 01/26/17 | Boston |
| Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More | Ben Fidler | 09/16/16 | National |
| Delinia Obtains $35,000,000 Series A Funding | VentureDeal | 09/15/16 | San Francisco |
| Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases | Ben Fidler | 09/14/16 | Boston |
